Early aspirin discontinuation linked to benefits in low-risk MI patients undergoing PCI: ESC Study
Madri: Among low-risk patients with acute MI who underwent early complete revascularisation and received one month of dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse cardiovascular and cerebrovascular events, while reducing bleeding risk. These late-breaking findings were presented in a Hot Line session today at ESC Congress 2025 and […]